Merieux Developpement

Total investments

36

Average round size

15M

Portfolio companies

27

Rounds per year

3.00

Lead investments

9

Follow on index

0.25

Exits

10

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsManufacturingMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsNursing and Residential Care

Summary

Merieux Developpement is the famous VC, which was founded in 2009. The main office of represented VC is situated in the Lyon. The company was established in Europe in France.

The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2018. The real fund results show that this VC is 18 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this Merieux Developpement works on 2 percentage points more the average amount of lead investments. The fund is constantly included in 2-6 deals per year.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Merieux Developpement, startups are often financed by Paladin Capital Group, Foresite Capital, NanoDimension. The meaningful sponsors for the fund in investment in the same round are NanoDimension, Shire, Paladin Capital Group. In the next rounds fund is usually obtained by Shire, Venrock, Paladin Capital Group.

The current fund was established by Francois Valencony. The overall number of key employees were 9.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Pharmaceutical, Manufacturing. Among the most popular portfolio startups of the fund, we may highlight Origene Technologies, Amphivena Therapeutics, Inscripta, Inc.

Show more

Investments analytics

Analytics

Total investments
36
Lead investments
9
Exits
10
Rounds per year
3.00
Follow on index
0.25
Investments by industry
  • Health Care (31)
  • Biotechnology (18)
  • Therapeutics (10)
  • Manufacturing (9)
  • Medical Device (9)
  • Show 30 more
Investments by region
  • United States (16)
  • France (12)
  • Israel (2)
  • Belgium (1)
  • Luxembourg (2)
  • Show 3 more
Peak activity year
2018
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
16
Avg. valuation at time of investment
176M
Group Appearance index
0.67
Avg. company exit year
17
Avg. multiplicator
5.36
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Amplitude 25 Jan 2012 Software, Analytics, SaaS, Product Management, Big Data, Manufacturing, Electronics, Electrical Distribution Early Stage Venture 35M Ile-de-France, Évry-Courcouronnes, France
MaulSoup 30 Jan 2010 Health Care Early Stage Venture 2M
PhysioAssist 18 Sep 2017 Health Care, Medical Device, Medical Early Stage Venture 7M France, Provence-Alpes-Côte d'Azur, Aix-en-Provence

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.